PMA device
TactiCath Contact Force Ablation Catheter, Sensor Enabled
St Jude Medical · Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE, Class III) · First FDA decision Dec 27, 2018, newest Oct 26, 2023Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
11
Naming "TactiCath"
MAUDE reports
3,067
Brand "TactiCath", since 2015
PubMed studies
57
Mentioning "TactiCath"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing TactiCath Contact Force Ablation Catheter, Sensor Enabled
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
P130026-S088 · Decided Oct 26, 2023 · 48 days after receipt · Normal 180 Day Track No User Fee
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
P130026-S077 · Decided Aug 17, 2022 · 257 days after receipt · Normal 180 Day Track No User Fee
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
P130026-S072 · Decided Mar 4, 2022 · 308 days after receipt · Normal 180 Day Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "TactiCath", any status and sponsor, newest update first.
- Pulsed Field Ablation of Atrial Fibrillation: CENTAURI Versus FARAPULSEPivotal-lookingCompleted
St. Anne's University Hospital Brno, Czech RepublicAcademic, hospital or other
NCT07902739 · 325 participants · Start May 17, 2024 · Primary completion Oct 5, 2026
Device: CENTAURI PEF system; FARAPULSE system · For: Atrial Fibrillation (AF); Paroxysmal AF; Persistent AF
Sites: Brno, Czechia
University Hospitals Coventry and Warwickshire NHS TrustAcademic, hospital or other
NCT06028919 · 61 participants · Start Sep 26, 2022 · Primary completion Nov 21, 2025
Device: Temperature controlled DiamondTemp (DT) ablation catheter; Tacticath/Tactiflex (TF) ablation catheter · For: Ventricular Tachycardia
Sites: Coventry, United Kingdom; Brighton, United Kingdom
- DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial FibrillationPivotal-lookingCompleted
Medtronic Cardiac Ablation SolutionsPublic (MDT)
NCT03334630 · 482 participants · Start Nov 6, 2017 · Primary completion Nov 18, 2019
Device: DiamondTemp Ablation catheter; TactiCath Quartz Ablation catheter · For: Paroxysmal Atrial Fibrillation; Atrial Fibrillation
Sites: Birmingham, Alabama; Los Angeles, California; Redwood City, California · 23 sites in all
8 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "TactiCath", and for the whole product code for context.
This brand
3,067 reports: 1,278 malfunction, 1,690 injury, 98 death
Whole product code OAE
11,261 reports: 5,551 malfunction, 5,370 injury, 334 death
Newest reports for this brand
3008452825-2026-00558 · Received Oct 19, 2026
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Cardiac Perforation
3008452825-2026-00552 · Received Oct 14, 2026 · Event dated Sep 30, 2026
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Device problem as coded: Activation, Positioning or Separation Problem
Patient problem as coded: Cardiac Perforation
3008452825-2026-00542 · Received Oct 9, 2026 · Event dated Sep 9, 2026
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Device problem as coded: Use of Device Problem
Patient problem as coded: Cardiac Perforation
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- TactiFlex Ablation Sensor Enabled Ablation Catheter, Models A-TFSE-FJ, 7.5 F shaft and an 8F distal section, Sterile.Open, Classified
St. Jude Medical, Atrial Fibrillation Division, Inc.
Z-0814-2024 · Started Dec 18, 2023 · Posted by FDA Jan 25, 2024
Reason given: When the catheters are used with the EnSiteX EP System, the system does not correctly recognize the catheter as the appropriate product model and instead reads and displays it as a different model. This results in some features specific to the catheter do not appear on the display and the catheter image may also...
Cause as FDA categorized it: Under Investigation by firm · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Z-0956-2022 · Started Mar 24, 2022
Reason given: Devices were manufactured with a "First Use Date" preprogrammed in the EEPROM which disables the use of the single-use device.
Cause as FDA categorized it: Process control · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Z-0957-2022 · Started Mar 24, 2022
Reason given: Devices were manufactured with a "First Use Date" preprogrammed in the EEPROM which disables the use of the single-use device.
Cause as FDA categorized it: Process control · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
3 more recall records with a free account
Published research
The most relevant PubMed records for "TactiCath"[tiab]. The summary above synthesizes these.
- Safety verification of a novel irrigation catheter with flexible tip of laser-cut kerfs and contact force sensor.
Yamaguchi J, Takigawa M, Goya M, et al. · Pacing Clin Electrophysiol · 2023Research Support, Non-U.S. Gov't
- Effects of Contact Force on Lesion Size During Pulsed Field Catheter Ablation: Histochemical Characterization of Ventricular Lesion Boundaries.
Nakagawa H, Castellvi Q, Neal R, et al. · Circ Arrhythm Electrophysiol · 2024Research Support, Non-U.S. Gov't
- Thermal Profiles for Focal Pulsed Electric Field Ablation.
Verma A, Zhong P, Castellvi Q, et al. · JACC Clin Electrophysiol · 2023
- Impact of tip design and thermocouple location on the efficacy and safety of radiofrequency application.
Yamaguchi J, Takigawa M, Goya M, et al. · J Interv Card Electrophysiol · 2023
- Contact force catheter ablation for the treatment of persistent atrial fibrillation: Results from the PERSIST-END study.
Lo M, Nair D, Mansour M, et al. · J Cardiovasc Electrophysiol · 2023Multicenter Study, Research Support, Non-U.S. Gov't
- Safety and Effectiveness of a Next-Generation Contact Force Catheter: Results of the TactiSense Trial.
Lo MY, Sanders P, Sommer P, et al. · JACC Clin Electrophysiol · 2021Clinical Trial, Multicenter Study
- Validation of the accuracy of contact force measurement by contemporary force-sensing ablation catheters.
Kueffer T, Haeberlin A, Knecht S, et al. · J Cardiovasc Electrophysiol · 2023Research Support, Non-U.S. Gov't
- Economic impact of contact force sensing in catheter ablation for atrial fibrillation.
Mansour M, Reddy VY, Karst E, et al. · J Cardiovasc Electrophysiol · 2019Multicenter Study, Research Support, Non-U.S. Gov't
- High-Power Short-Duration Posterior Wall Isolation in Addition to Pulmonary Vein Isolation in Persistent Atrial Fibrillation Ablation Using the New TactiFlexࡊ Ablation Catheter.
Conti S, Sabatino F, Randazzo G, et al. · J Cardiovasc Dev Dis · 2024
- Contact force guided radiofrequency current application at developing myocardium.
Backhoff D, Müller MJ, Betz T, et al. · J Cardiovasc Electrophysiol · 2022Research Support, Non-U.S. Gov't
- In vivo Lesion Index (LSI) validation in percutaneous radiofrequency catheter ablation.
Themistoclakis S, Calzolari V, De Mattia L, et al. · J Cardiovasc Electrophysiol · 2022Research Support, Non-U.S. Gov't
- Characteristics of tissue temperature during ablation with THERMOCOOL SMARTTOUCH SF versus TactiCath versus QDOT MICRO catheters (Qmode and Qmode+): An in vivo porcine study.
Otsuka N, Okumura Y, Kuorkawa S, et al. · J Cardiovasc Electrophysiol · 2024Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code OAE.
- Arctic Front Advance and Arctic Front Advance ProMedtronic Cryocath, LP · PMA 2024
- Arctic Front Cardiac Cryoablation Catheter SystemMedtronic Cryocath, LP · PMA 2024
- HeartLight Catheter, HeartLight X3 Console V2Cardiofocus, Inc. · PMA 2023
- TactiFlex Sensor Enabled Ablation CatheterAbbott Medical · PMA 2026
- DiamondTemp Ablation SystemMedtronic, Inc. · PMA 2025
- TactiCath Quartz Contact Force Ablation CatheterSt Jude Medical · PMA 2021
- QDOT MICRO SystemBiosense Webster, Inc. · PMA 2025
- POLARx/POLARx FIT Cryoablation CathetersBoston Scientific Corporation · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.